Identifying the EMT-related signature to stratify prognosis and evaluate the tumor microenvironment in lung adenocarcinoma

Identifying the EMT-related signature to stratify prognosis and evaluate the tumor microenvironment in lung adenocarcinoma

Background: Epithelial-mesenchymal transition (EMT) is a critical process in tumor invasion and metastasis. EMT has been shown to significantly influence the invasion, metastasis, and poor prognosis in lung adenocarcinoma (LUAD). This study aimed to develop a novel EMT-related prognostic model capab...

Full description

Bibliographic Details
Main Authors:	Feng Li, Qing-Zhen Song, Yi-Fan Zhang, Xing-Ru Wang, Li-Min Cao, Nan Li, Ling-Xia Zhao, Sheng-Xiao Zhang, Xiao-Fei Zhuang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-09-01
Series:	Frontiers in Genetics
Subjects:	epithelial-mesenchymal transition lung adenocarcinoma prognosis tumor immune microenvironment immunotherapy chemotherapy
Online Access:	https://www.frontiersin.org/articles/10.3389/fgene.2022.1008416/full

Similar Items

Multicenter cohort analysis of anoikis and EMT: implications for prognosis and therapy in lung adenocarcinoma
by: Lu Yin, et al.
Published: (2024-09-01)

Generation of novel lipid metabolism-based signatures to predict prognosis and immunotherapy response for colorectal adenocarcinoma
by: Yi Wang, et al.
Published: (2024-07-01)

Prognosis and clinical features analysis of EMT-related signature and tumor Immune microenvironment in glioma
by: Xiao Zheng, et al.
Published: (2023-01-01)

Identification of a prognostic classifier based on EMT-related lncRNAs and the function of LINC01138 in tumor progression for lung adenocarcinoma
by: Lingyan Xiao, et al.
Published: (2022-08-01)

An epithelial–mesenchymal transition-related mRNA signature associated with the prognosis, immune infiltration and therapeutic response of colon adenocarcinoma
by: Yu Zhang, et al.
Published: (2023-02-01)

A novel genomic instability-derived lncRNA signature to predict prognosis and immune characteristics of pancreatic ductal adenocarcinoma
by: Huijie Yang, et al.
Published: (2022-09-01)

E-Cadherin in Pancreatic Ductal Adenocarcinoma: A Multifaceted Actor during EMT
by: Michele Sommariva, et al.
Published: (2020-04-01)

A Five Collagen-Related Gene Signature to Estimate the Prognosis and Immune Microenvironment in Clear Cell Renal Cell Cancer
by: Xiaokai Shi, et al.
Published: (2021-12-01)

SUMOylation patterns and signature characterize the tumor microenvironment and predict prognosis in lung adenocarcinoma
by: Zhike Chen, et al.
Published: (2023-04-01)

Cuproptosis-related lncRNA signatures: Predicting prognosis and evaluating the tumor immune microenvironment in lung adenocarcinoma
by: Pengpeng Zhang, et al.
Published: (2023-01-01)

The mechanism of lncRNAs in the crosstalk between epithelial-mesenchymal transition and tumor microenvironment for early colon adenocarcinoma based on molecular subtyping
by: Hanlin Liang, et al.
Published: (2022-11-01)

Identification of Four Genes as Prognosis Signatures in Lung Adenocarcinoma Microenvironment
by: Yao Y, et al.
Published: (2021-01-01)

Single-Cell RNA-Seq Reveals the Promoting Role of Ferroptosis Tendency During Lung Adenocarcinoma EMT Progression
by: Jiaxi Yao, et al.
Published: (2022-01-01)

Identification of a novel anoikis‐related gene signature to predict prognosis and tumor microenvironment in lung adenocarcinoma
by: Xiayao Diao, et al.
Published: (2023-01-01)

An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma
by: Cong Liu, et al.
Published: (2022-07-01)

A disulfidptosis-related lncRNA signature for predicting prognosis and evaluating the tumor immune microenvironment of lung adenocarcinoma
by: Zipei Song, et al.
Published: (2024-02-01)

Identification of Epithelial–Mesenchymal Transition-Related Prognostic lncRNAs Biomarkers Associated With Melanoma Microenvironment
by: Bo Xiao, et al.
Published: (2021-05-01)

A novel epithelial-mesenchymal transition-related gene signature for prognosis prediction in patients with lung adenocarcinoma
by: Shengyu Feng, et al.
Published: (2022-01-01)

Network Pharmacology and Experimental Evidence Reveal Dioscin Suppresses Proliferation, Invasion, and EMT via AKT/GSK3b/mTOR Signaling in Lung Adenocarcinoma
by: Mao W, et al.
Published: (2020-05-01)

Identification of a Gene Signature Closely Related to Immunosuppressive Tumour Microenvironment Predicting Prognosis of Patients in EGFR Mutant Lung Adenocarcinoma
by: Jia Li, et al.
Published: (2021-09-01)

Pediatric cancer—pathology and microenvironment influence: a perspective into osteosarcoma and non-osteogenic mesenchymal malignant neoplasms
by: Consolato M. Sergi
Published: (2024-08-01)

Five EMT‐related genes signature predicts overall survival and immune environment in microsatellite instability‐high gastric cancer
by: Mili Zhang, et al.
Published: (2023-01-01)

Action of m6A-related gene signatures on the prognosis and immune microenvironment of colonic adenocarcinoma
by: Han Shugao, et al.
Published: (2024-06-01)

Biophysics Role and Biomimetic Culture Systems of ECM Stiffness in Cancer EMT
by: Hao Tian, et al.
Published: (2022-06-01)

A novel signature predicts prognosis and immunotherapy in lung adenocarcinoma based on cancer-associated fibroblasts
by: Qianhe Ren, et al.
Published: (2023-05-01)

Identification of a Novel Tumor Microenvironment–Associated Eight-Gene Signature for Prognosis Prediction in Lung Adenocarcinoma
by: Chao Ma, et al.
Published: (2020-09-01)

Aquaporin 1 Is an Independent Marker of Poor Prognosis in Lung Adenocarcinoma
by: Sumi Yun, et al.
Published: (2016-07-01)

Identification and validation of an immune signature associated with EMT and metabolic reprogramming for predicting prognosis and drug response in bladder cancer
by: Zhao Zhang, et al.
Published: (2022-07-01)

Construction of a mitophagy-related prognostic signature for predicting prognosis and tumor microenvironment in lung adenocarcinoma
by: Wu-Sheng Liu, et al.
Published: (2024-08-01)

Integrative stemness characteristics associated with prognosis and the immune microenvironment in lung adenocarcinoma
by: Han Wang, et al.
Published: (2022-12-01)

SEC61 translocon gamma subunit is correlated with glycolytic activity, epithelial mesenchymal transition and the immune suppressive phenotype of lung adenocarcinoma
by: Zhou Changshuai, et al.
Published: (2024-07-01)

Construction of shared gene signature between rheumatoid arthritis and lung adenocarcinoma helps to predict the prognosis and tumor microenvironment of the LUAD patients
by: Liping Shi, et al.
Published: (2024-01-01)

Cystatin SN promotes epithelial-mesenchymal transition and serves as a prognostic biomarker in lung adenocarcinoma
by: Jian Yang, et al.
Published: (2022-05-01)

IL6-STAT3-C/EBPβ-IL6 positive feedback loop in tumor-associated macrophages promotes the EMT and metastasis of lung adenocarcinoma
by: Zhengyang Hu, et al.
Published: (2024-02-01)

Identifying a lactic acid metabolism-related gene signature contributes to predicting prognosis, immunotherapy efficacy, and tumor microenvironment of lung adenocarcinoma
by: Fangchao Zhao, et al.
Published: (2022-10-01)

Tumor‐driven like macrophages induced by conditioned media from pancreatic ductal adenocarcinoma promote tumor metastasis via secreting IL‐8
by: Shao‐jie Chen, et al.
Published: (2018-11-01)

Identification of a Three-Gene Signature Based on Epithelial-Mesenchymal Transition of Lung Adenocarcinoma Through Construction and Validation of a Risk-Prediction Model
by: Jianguang Shi, et al.
Published: (2021-10-01)

Identification of a glycolysis- and lactate-related gene signature for predicting prognosis, immune microenvironment, and drug candidates in colon adenocarcinoma
by: Cong Liu, et al.
Published: (2022-08-01)

Molecular Characterization and Prognosis of Lactate-Related Genes in Lung Adenocarcinoma
by: Zixin Guo, et al.
Published: (2023-02-01)

A Comprehensive Analysis of Pyroptosis-Related lncRNAs Signature Associated With Prognosis and Tumor Immune Microenvironment of Pancreatic Adenocarcinoma
by: Kai Zhao, et al.
Published: (2022-07-01)